Purpose of the Procedure
- Providing prognostic information regarding disease progression.
- Monitoring patient response to chemotherapy or hormonal therapy.
- Early detection of potential tumor recurrence or metastasis.
Book CTC Tumor Cell Test in Saudi Arabia | Lahalak Medical Platform
A cutting-edge liquid biopsy test monitoring cancer treatment efficacy by counting tumor cells in the blood for breast, prostate, and colorectal cancer patients, facilitating precise prognostic insights and clinical decisions.
Scientific name: Circulating Tumor Cells (CTC) Enumeration Test
The CTC test is an advanced liquid biopsy measuring cancer cells that detached from primary tumors into the bloodstream. It evaluates treatment response in metastatic breast, prostate, and colorectal cancers.
Service type
Laboratory test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Venous blood draw
- Tumor cell enumeration analysis
- Detailed laboratory report
Medical Service Information
Target Groups
- Patients with metastatic breast cancer.
- Patients with advanced prostate cancer.
- Patients with metastatic colorectal cancer.
Understanding Results
- A decrease in CTC count usually indicates a favorable response to treatment.
- An increase in CTC count may suggest the need to re-evaluate the treatment plan.
- Results must always be discussed with a specialized oncologist.
Conditions & Notices
- Preferably performed before starting a new treatment cycle or after a period specified by the physician
Medical services you might also like
